Skip to main navigation Skip to search Skip to main content

TRITC-Loaded PLGA Nanoparticles as Drug Delivery Carriers in Mouse Oocytes and Embryos

  • Hye Jin Kim
  • , Sujin Lee
  • , Ju Hyun Lee
  • , Jong Min Park
  • , Suk Jun Hong
  • , Ok Hee Lee
  • , Ji Sun Park
  • , Youngsok Choi
  • , Keun Hong Park
  • CHA University

Research output: Contribution to journal › Article › peer-review

8 Scopus citations

Abstract

The structural layers around oocytes make it difficult to deliver drugs aimed at treating infertility. In this study, we sought to identify nanoparticles (NPs) that could easily pass through zona pellucida (ZP), a special layer around oocytes, for use as a drug delivery carrier. Three types of NPs were tested: quantum dot NPs, PE-polyethylene glycol (PEG)-loaded poly(lactic-co-glycolic acid) (PLGA) NPs (PEG/PL), and tetramethylrhodamine-loaded PLGA NPs (TRNPs). When mouse oocytes were treated with NPs, only TRNPs could fully pass through the ZP and cell membrane. To assess the effects of TRNPs on fertility and potential nanotoxicity, we performed mRNA sequencing analysis to confirm their genetic safety. We established a system to successfully internalize TRNPs into oocytes. The genetic stability and normal development of TRNP-treated oocytes and embryos were confirmed. These results imply that TRNPs can be used as a drug delivery carrier applicable to germ cells.

Original languageEnglish
Pages (from-to)5975-5988
Number of pages14
JournalACS Applied Materials and Interfaces
Volume13
Issue number5
DOIs
StatePublished - 10 Feb 2021

Keywords

  • genetic stability
  • mouse oocyte
  • oocyte maturation
  • poly(lactic-co-glycolic acid) (PLGA)
  • preimplantation embryonic development
  • tetramethylrhodamine (TRITC)

Fingerprint

Dive into the research topics of 'TRITC-Loaded PLGA Nanoparticles as Drug Delivery Carriers in Mouse Oocytes and Embryos'. Together they form a unique fingerprint.

Cite this